Capricor Therapeutics, Inc.
US ˙ NasdaqGS ˙ US14070B3096

SecurityCAPR / Capricor Therapeutics, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership11,036 shares
Latest Disclosed Value $ 335,494
Citigroup Inc ownership in CAPR / Capricor Therapeutics, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 11,036 shares of Capricor Therapeutics, Inc. (US:CAPR) valued at $335,494 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,859 shares of Capricor Therapeutics, Inc.. This represents a change in shares of 286.01% during the quarter. The current value of the position is $305,035 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (CAPR) in the form of stock options. The firm currently holds call options representing 31,500 of underlying shares valued at $957,600 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

CAPR / Capricor Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 11,036 8,177 286.01 335 308.54 0.0001
2026-02-13 2025-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 2,859 -4,061 -58.68 83 67.35 0.0000
2025-11-10 2025-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 6,920 -22,608 -76.56 50 -83.28 0.0000
2025-08-11 2025-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 29,528 -64,676 -68.66 293 -67.19 0.0001
2025-05-12 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 94,204 295 0.31 894 -31.04 0.0005
2025-02-12 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 93,909 73,456 359.15 1,296 316.40 0.0008
2024-11-12 2024-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 20,453 9,190 81.59 311 486.79 0.0002
2024-08-12 2024-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 11,263 -67,089 -85.63 54 -90.04 0.0000
2024-05-10 2024-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 78,352 54,554 229.24 532 358.62 0.0003
2024-02-09 2023-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 23,798 -37,793 -61.36 116 -44.76 0.0001
2023-12-06 2023-09-30 13F/A-1 CAPRICOR THERAPEUTICS COM NEW 14070B309 61,591 61,591 211 0.0002
2023-11-09 2023-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 61,591 61,591 211 0.0002
2022-08-10 2022-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -20 -100.00 0 0.0000
2022-05-12 2022-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 20 20 0 0.0000
2021-05-13 2021-03-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 0 -900 -100.00 0 -100.00
2021-02-11 2020-12-31 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 900 -200 -18.18 3 -50.00 0.0000
2020-11-12 2020-09-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 1,100 0 0.00 6 20.00 0.0000
2020-08-12 2020-06-30 13F CAPRICOR THERAPEUTICS COM NEW 14070B309 1,100 1,100 5 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 31,500 958 n/a n/a n/a
2025-05-12 2025-03-31 13F CAPRICOR THERAPEUTICS COM NEW Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-12 2024-12-31 13F CAPRICOR THERAPEUTICS COM NEW Call 10,000 138 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.